The Xi-Trump summit in Beijing unfolded much more cordially than the tense truce in Busan. In the six months since the leaders met in the South Korean city, America’s bargaining position has weakened considerably from developments both domestic and international. From a reluctant respite in tensions, US-China relations have evolved to what may be the beginning of a reconciliation. The two great po...
The Xi-Trump summit in Beijing unfolded much more cordially than the tense truce in Busan. In the six months since the leaders met in the South Korean city, America’s bargaining position has weakened considerably from developments both domestic and international. From a reluctant respite in tensions, US-China relations have evolved to what may be the beginning of a reconciliation. The two great powers interact at three levels. At the bottom is trade and investment; we can expect the terms of the Busan trade truce to be revised as the context evolves. At the top is geopolitical rivalry – with an America drained by the Iran war. In the middle is the most strategic layer, involving technology and critical supply chains, shaping cooperation in the level below and constraining conflict in the level above. The bottom layer is the easiest to self-maintain. In Beijing, the United States and China agreed to set up separate boards to manage bilateral trade and investment. These boards primarily cover non-sensitive sectors, however, and function well only if there is strategic stability in the top layer. Advertisement Trump’s trade war against the world is losing steam. The US Supreme Court and Court of International Trade have ruled that Trump’s tariffs are invalid. Despite the Section 301 trade investigations against China, given the understanding reached at the pre-Beijing talks in Seoul, US tariffs may be capped at levels established in last year’s truce. Furthermore, the bid to leverage tariffs to narrow US trade deficits and suppress China’s exports has largely failed. Last year, the US goods trade deficit hit a record of US$1.24 trillion while China reported a record trade surplus of US$1.2 trillion. Although the US trade deficit with China shrunk, this has neither helped the US nor hurt China – the US has merely shifted import sources while China diversified its export markets. Even as trade flows are reconfigured, the overall trade balances for US and China hardly bud...
BEIJING, May 26, 2026 (GLOBE NEWSWIRE) -- Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial and Operational Snapshots Net revenues were RMB440.7 million (US$...
BEIJING, May 26, 2026 (GLOBE NEWSWIRE) -- Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial and Operational Snapshots Net revenues were RMB440.7 million (US$63.9 million), compared to RMB487.6 million in the first quarter of 2025. Gross billings (non-GAAP) were RMB304.8 million (US$44.2 million), compared to RMB412.3 million in the first quarter of 2025. Gross profit was RMB381.1 million (US$55.3 million), compared to RMB415.3 million in the first quarter of 2025. Net income was RMB76.8 million (US$11.1 million), compared to RMB75.2 million in the first quarter of 2025. Net income margin 1 was 17.4%, compared to 15.4% in the first quarter of 2025. was 17.4%, compared to 15.4% in the first quarter of 2025. New student enrollments 2 were 102,127, compared to 169,083 in the first quarter of 2025. were 102,127, compared to 169,083 in the first quarter of 2025. As of March 31, 2026, the Company’s deferred revenue balance was RMB500.5 million (US$72.6 million), compared to RMB585.3 million as of December 31, 2025. _____________________________ 1 Net income margin is defined as net income as a percentage of net revenues. 2 New student enrollments for a given period refer to the total number of orders placed by students that newly enroll in at least one course during that period, including those students that enroll and then terminate their enrollment with us, excluding orders of our low-price courses, such as “mini courses” and “RMB1 courses”, which we offer in the form of recorded videos or short live streaming, to strengthen our competitiveness and improve customer experience. “We opened 2026 with net revenues of RMB440.7 million and net income of RMB76.8 million, our 20th consecutive profitable quarter. Net income margin remained s...
Conflict is intensfying around the world, from Latin America to the Middle East to potentially the Pacific. In preparation for a less peaceful future, the U.S. is substantially increasing its defense budget, boosting it by 44% to $1.5 trillion in 2027 alone. Full budgets are not out yet, but it is clear there will be a huge rise in spending on new military technologies and in stockpiles of key pro...
Conflict is intensfying around the world, from Latin America to the Middle East to potentially the Pacific. In preparation for a less peaceful future, the U.S. is substantially increasing its defense budget, boosting it by 44% to $1.5 trillion in 2027 alone. Full budgets are not out yet, but it is clear there will be a huge rise in spending on new military technologies and in stockpiles of key products, such as missile defense systems. Many stocks can benefit as suppliers to this new arsenal of democracy. Here are two defense stocks worth looking at. Anyone following the war in Ukraine knows that drones are the future of warfare. In land-based conflict, this means drones in the air. But for sea-based conflict, the U.S. Navy is increasing its defense and attack capabilities with underwater drones. The contractors making these drones can overlap with air drones such as start-up Anduril, but it is in a much earlier growth phase, with research and procurement only beginning now. Continue reading
Some palm oil refiners in Indonesia are avoiding buying fruit from small farmers, a sign of how the government’s commodity export overhaul risks squeezing grower incomes and crimping supplies of the crop. Several processors have stopped purchasing fresh fruit bunches from smallholders while they wait for clarity on the new export framework, according to people familiar with the matter. Large refin...
Some palm oil refiners in Indonesia are avoiding buying fruit from small farmers, a sign of how the government’s commodity export overhaul risks squeezing grower incomes and crimping supplies of the crop. Several processors have stopped purchasing fresh fruit bunches from smallholders while they wait for clarity on the new export framework, according to people familiar with the matter. Large refiners that already have sufficient supply from their own plantations are, meanwhile, choosing to avoid spot purchases due to the policy uncertainty, the people said, asking not to be named as they’re not authorized to speak to media. President Prabowo Subianto last week unveiled plans for the government to take direct control over exports of some of the nation’s most important commodities. Danantara Sumberdaya Indonesia, a new entity under one of Indonesia’s sovereign wealth fund, will start by taking over export management of palm oil, thermal coal and some nickel products — markets that Indonesia dominates. Prabowo has said the policy is aimed at increasing transparency and curbing tax evasion, but, in the short term at least, it has rattled investors and whipsawed palm markets. State-linked tenders, which serve as a benchmark for domestic crude palm oil prices and export offers, have ground to a halt since the announcement as buyers slashed bids for spot cargoes, even as Malaysian palm futures climbed. Benchmark futures in Kuala Lumpur rose as much as 0.8% on Tuesday. Indonesia’s government, along with business operators and palm oil farmer associations, has agreed on steps to maintain the stability of prices and ensure smooth implementation of the new export policy, Deputy Minister of Agriculture Sudaryono said in a statement, following a meeting with industry stakeholders on Tuesday. The volatility in prices is being driven by “psychological fears,” including uncertainty and a lack of understanding on how the new regulations will work, Sudaryono said. After the meeting, ...
Key Points Claiming spousal benefits from Social Security before full retirement age could result in reduced monthly checks. Once full retirement age arrives, there's no sense in waiting. Spousal benefits aren't eligible for delayed retirement credits, and waiting too long to file could cost you a boatload of money. The $23,760 Social Security bonus most retirees completely overlook › There's a lo...
Key Points Claiming spousal benefits from Social Security before full retirement age could result in reduced monthly checks. Once full retirement age arrives, there's no sense in waiting. Spousal benefits aren't eligible for delayed retirement credits, and waiting too long to file could cost you a boatload of money. The $23,760 Social Security bonus most retirees completely overlook › There's a lot riding on your Social Security filing decision. That's because the age at which you take benefits has a direct impact on the amount of money you receive each month. This applies to Social Security benefits you collect in retirement based on your personal wage history as well as spousal benefits. When you're filing for Social Security benefits based on your own earnings record, there's a huge upside to delaying your claim past full retirement age. But that upside doesn't exist in the world of spousal benefits. And recognizing that could spare you from making a potentially huge mistake. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Get your spousal benefit timing right Spousal benefits from Social Security could be a financial lifeline for you in retirement. So it's important to file strategically. As is the case with benefits you're claiming on your own earnings record, you can sign up for spousal benefits starting at age 62. But if you don't wait until full retirement age to claim spousal benefits, those monthly checks will be reduced permanently. Full retirement age is 67 for anyone born in 1960 or later. Now when you're claiming Social Security based on your own earnings record, there's a huge incentive to hold off past full retirement age. Each year you wait up until age 70 boosts your monthly checks by 8%. But those delayed retirement credits don't apply to spousal benefits. Rather, spousal benefi...
BalkansCat/iStock Editorial via Getty Images I often say very clearly that some upsides (or downsides, for that matter) cannot be forecasted. But I also say that in some cases, the undervaluation in the cases of some companies is so very clear that there's no question whether there will be upside. The question is not if, but when. ams-OSRAM AG ( AMSSY ) was one such company and still to this day (...
BalkansCat/iStock Editorial via Getty Images I often say very clearly that some upsides (or downsides, for that matter) cannot be forecasted. But I also say that in some cases, the undervaluation in the cases of some companies is so very clear that there's no question whether there will be upside. The question is not if, but when. ams-OSRAM AG ( AMSSY ) was one such company and still to this day (at least for the time being) is one such company. I invested a bit (not much, but above 0.2%) at sub-$3/share for the ADR, in accordance with my last article on the company found here. You can see the return on that investment here. Seeking Alpha AMS Osram RoR Now, a few disclaimers on this one, since we're talking about a 410%+ return in less than 2 years, which is more than 15x the development of the SPY, which was also great. First, no, I was unable to forecast exactly this, nor the timing of when this occurred—obviously. If I had, I would have invested a lot more than 0.2% of my portfolio; I can tell you that much. Secondly, the company is still a risky business—again, reflected in my overall allocation size. However, there are a few things I'm willing to take credit for. Firstly, I forecasted a potential recovery by the 2026-2027 period. This has materialized. I further forecasted a return to positive results and better fundamental trends. This, too, has occurred. Out of most analysts on SA, I believe, based on articles, only I and one other analyst saw any sort of appeal in this. And when it comes to that, I also obviously didn't see the degree of reversal appeal. But this is where we now are. So, because we're now at a 400%+ return in the midst of a surging market, this requires a stance from me. I need to decide what to do with the position, which is now above 1.2% of my portfolio. It's a meaningful improvement, and what was a slightly small position has actually grown into a respectable size. So do I rotate, or do I keep it? And if either, what do I base this decis...
Key Points Inflationary pressures are calling Wall Street's bull market rally into question. The Iran war is taking its toll, with gas prices rising faster than they have in three decades. While the Cleveland Fed's Inflation Nowcasting tool offers a silver lining, it also points to growing risk of Federal Open Market Committee (FOMC) interest rate hikes. 10 stocks we like better than S&P 500 Index...
Key Points Inflationary pressures are calling Wall Street's bull market rally into question. The Iran war is taking its toll, with gas prices rising faster than they have in three decades. While the Cleveland Fed's Inflation Nowcasting tool offers a silver lining, it also points to growing risk of Federal Open Market Committee (FOMC) interest rate hikes. 10 stocks we like better than S&P 500 Index › Within the last two weeks, we've witnessed the iconic Dow Jones Industrial Average (DJINDICES: ^DJI), benchmark S&P 500 (SNPINDEX: ^GSPC), and artificial intelligence (AI)-driven Nasdaq Composite (NASDAQINDEX: ^IXIC) reach all-time highs. But the sustainability of this bull market rally is being firmly called into question by rapidly rising inflation. While the latest May inflation update from the Federal Reserve offered the first glimmer of hope in weeks, the bad news continues to handily outweigh any silver linings for Wall Street. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » The Iran war is taking its toll Although now-former Fed Chair Jerome Powell repeatedly called out President Donald Trump's tariffs and their price stickiness in the goods sector for elevated inflation, the bulk of the inflationary pressures right now trace back to the Iran war. Since Trump gave the order for the U.S. military to attack Iran on Feb. 28, the latter has shut down the Strait of Hormuz to most commercial traffic. This includes halting the movement of approximately 20 million barrels of petroleum liquids per day (about 20% of worldwide demand). ⛽ Average U.S. gas prices per gallon on May 6, per AAA: • Regular: $4.54 (⬆️ $1.56 since war in Iran began on Feb. 28) • Premium: $5.39 (⬆️ $1.85 since war began) • Diesel: $5.67 (⬆️ $1.81 since war began) -- NBC News (@NBCNews) May 6, 2026 The largest energy supply disrupti...
Torsten Asmus The semi-annual rebalancing of U.S. equities is officially underway after FTSE Russell unveiled its preliminary list of shifts for the broad-market Russell 3000 Index on Monday . Highlighting a major sector realignment across the healthcare and biotech landscapes: Expected Additions: Ocugen ( OCGN ), Senseonics ( SENS ), Nektar Therapeutics ( NKTR ), Agenus ( AGEN ), and CytomX Thera...
Torsten Asmus The semi-annual rebalancing of U.S. equities is officially underway after FTSE Russell unveiled its preliminary list of shifts for the broad-market Russell 3000 Index on Monday . Highlighting a major sector realignment across the healthcare and biotech landscapes: Expected Additions: Ocugen ( OCGN ), Senseonics ( SENS ), Nektar Therapeutics ( NKTR ), Agenus ( AGEN ), and CytomX Therapeutics ( CTMX ). Expected Deletions: Nano-X Imaging ( NNOX ), Tvardi Therapeutics ( TVRD ), Fate Therapeutics ( FATE ), Quantum-Si Incorporated ( QSI ), and Cardiff Oncology ( CRDF ). This year's historic structural changes will officially take effect following the close of U.S. equity markets on Friday, June 26 . More on the top constituents of the Russell 3000 Index Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript Fate: 'Hold' FT819 Regimen B Dosing And Potential FDA Alignment In H2 2026 Nano-X Imaging: Too Cheap To Ignore, Too Early To Buy Ocugen, Assertio among healthcare stocks set to join Russell Microcap; Definium Therapeutics, Tvardi Therapeutics to exit Cardiff Oncology GAAP EPS of -$0.18 misses by $0.05, revenue of $0.04M misses by $0.04M
Key Points The weight loss opportunity is a significant one for companies and investors -- and companies involved have seen their shares soar. Analysts predict the market will reach almost $100 billion within a few years. 10 stocks we like better than Viking Therapeutics › Investors have piled into pharma and biotech companies involved in the obesity drug space in recent years -- and for good reas...
Key Points The weight loss opportunity is a significant one for companies and investors -- and companies involved have seen their shares soar. Analysts predict the market will reach almost $100 billion within a few years. 10 stocks we like better than Viking Therapeutics › Investors have piled into pharma and biotech companies involved in the obesity drug space in recent years -- and for good reason. The market is on track to reach nearly $100 billion by the end of the decade. Meanwhile, we've seen plenty of evidence supporting this growth forecast, from high demand for currently commercialized obesity drugs to blockbuster revenue. Today, Eli Lilly and Novo Nordisk dominate the market with their weight loss drugs, but these aren't the only companies that may score a win for investors. Many other drugmakers are studying candidates in clinical trials and could join this high-growth market down the road. Before that happens, they might announce trial results and other progress that could spur investor optimism and result in big gains for their stock prices. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » In fact, my prediction is that these two obesity drug stocks could double in 2026. Let's check them out. 1. Viking Therapeutics Viking Therapeutics (NASDAQ: VKTX) is a clinical-stage biotech specializing in treatment for metabolic diseases, so it's perfectly positioned to work in the weight loss space. The candidate everyone has been watching is VK-2735, a dual GLP-1/GIP receptor agonist that works in much the same way as the Lilly and Novo drugs. The GLP-1 class of drugs stimulates hormonal pathways involved in processes such as managing blood sugar levels and appetite. Lilly and Novo have sold injectable formulations for the past several years, and just recently, they both won approval for oral dru...
Bleakley Financial Group LLC increased its position in shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 7.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 59,923 shares of the semiconductor company's stock after buying an additional 4,221 shares during the quarter. Bleakley Financial Gro...
Bleakley Financial Group LLC increased its position in shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 7.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 59,923 shares of the semiconductor company's stock after buying an additional 4,221 shares during the quarter. Bleakley Financial Group LLC's holdings in Taiwan Semiconductor Manufacturing were worth $18,210,000 as of its most recent SEC filing. Get TSM alerts: Sign Up Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Oak Harvest Investment Services grew its stake in shares of Taiwan Semiconductor Manufacturing by 2.9% in the 4th quarter. Oak Harvest Investment Services now owns 1,106 shares of the semiconductor company's stock valued at $336,000 after purchasing an additional 31 shares during the last quarter. Falcon Wealth Planning grew its stake in shares of Taiwan Semiconductor Manufacturing by 4.4% in the 4th quarter. Falcon Wealth Planning now owns 780 shares of the semiconductor company's stock valued at $237,000 after purchasing an additional 33 shares during the last quarter. Drive Wealth Management LLC grew its stake in shares of Taiwan Semiconductor Manufacturing by 0.7% in the 4th quarter. Drive Wealth Management LLC now owns 4,997 shares of the semiconductor company's stock valued at $1,522,000 after purchasing an additional 33 shares during the last quarter. Sovereign Financial Group Inc. grew its stake in shares of Taiwan Semiconductor Manufacturing by 4.5% in the 4th quarter. Sovereign Financial Group Inc. now owns 793 shares of the semiconductor company's stock valued at $241,000 after purchasing an additional 34 shares during the last quarter. Finally, Avion Wealth grew its stake in shares of Taiwan Semiconductor Manufacturing by 10.8% in the 4th quarter. Avion Wealth now owns 349 shares of the semiconductor company's stock v...
The boss of Next has sounded the alarm about a “dramatic fall” in the number of entry-level jobs in the UK and its impact on youth unemployment, saying the retailer now receives twice as many applicants for each role than two years ago. Lord Wolfson said the clothing and homeware chain, where he has been chief executive since 2001, typically received 10 applications for every job in its shops in 2...
The boss of Next has sounded the alarm about a “dramatic fall” in the number of entry-level jobs in the UK and its impact on youth unemployment, saying the retailer now receives twice as many applicants for each role than two years ago. Lord Wolfson said the clothing and homeware chain, where he has been chief executive since 2001, typically received 10 applications for every job in its shops in 2024 but that number has now risen to 19. “That doubling of applicants for shop jobs is indicative of just how big the crisis is in youth unemployment at the moment,” he told the BBC. Wolfson’s comments came as a report commissioned by the government is expected to find that Labour has failed to tackle the soaring number of people not in education, employment or training (Neet) and must launch a “system reset” involving a fresh attempt to overhaul health and disability benefits. Alan Milburn, who is leading a review into why almost a million young people are Neet, said ministers had so far responded with a series of disjointed jobs programmes, rather than a cohesive strategy. Wolfson said a ban on zero-hours contracts coming in from next year, which is included in the government’s Employment Rights Act, would make hiring more difficult. The government says the contracts are “exploitative” and argues its legislation ends “one-sided flexibility” by making companies provide a “baseline” of security and predictability for staff. More than a million people in the UK are working on a zero-hours contract basis, in areas ranging from hospitality and warehouses to the NHS. Hundreds of thousands of them are on zero-hours contracts despite working for the same employer for years, according to the TUC. Wolfson, who received a record pay package of more than £7m last year, also called on the government to reverse the rise in national insurance contributions (NICs) employers have to pay, along with minimum wage rises. However, the Conservative peer suggested the best way to improve the jo...
Bleakley Financial Group LLC increased its position in Tesla, Inc. (NASDAQ:TSLA - Free Report) by 7.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 102,669 shares of the electric vehicle producer's stock after acquiring an additional 7,440 shares during the period. Bleakley Financial Group LLC's holdings in Tesl...
Bleakley Financial Group LLC increased its position in Tesla, Inc. (NASDAQ:TSLA - Free Report) by 7.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 102,669 shares of the electric vehicle producer's stock after acquiring an additional 7,440 shares during the period. Bleakley Financial Group LLC's holdings in Tesla were worth $46,172,000 at the end of the most recent reporting period. Other hedge funds also recently added to or reduced their stakes in the company. Crestwood Advisors Group LLC boosted its holdings in Tesla by 34.7% in the 4th quarter. Crestwood Advisors Group LLC now owns 19,567 shares of the electric vehicle producer's stock worth $8,799,000 after buying an additional 5,039 shares during the period. Gamco Investors INC. ET AL boosted its holdings in Tesla by 29.6% in the 3rd quarter. Gamco Investors INC. ET AL now owns 32,576 shares of the electric vehicle producer's stock worth $14,487,000 after buying an additional 7,446 shares during the period. China Universal Asset Management Co. Ltd. boosted its holdings in Tesla by 8.8% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 48,504 shares of the electric vehicle producer's stock worth $21,571,000 after buying an additional 3,935 shares during the period. Calamos Wealth Management LLC boosted its holdings in Tesla by 5.9% in the 4th quarter. Calamos Wealth Management LLC now owns 41,907 shares of the electric vehicle producer's stock worth $18,846,000 after buying an additional 2,341 shares during the period. Finally, Ashton Thomas Private Wealth LLC boosted its holdings in Tesla by 26.0% in the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 18,032 shares of the electric vehicle producer's stock worth $8,019,000 after buying an additional 3,724 shares during the period. 66.20% of the stock is currently owned by hedge funds and other institutional investors. Get Tesla alerts: Sign Up Key ...
Box Hill Private Wealth LLC bought a new stake in Tesla, Inc. (NASDAQ:TSLA - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 5,940 shares of the electric vehicle producer's stock, valued at approximately $2,671,000. Tesla comprises about 2.7% of Box Hill Private Wealth LLC's investment portfolio, makin...
Box Hill Private Wealth LLC bought a new stake in Tesla, Inc. (NASDAQ:TSLA - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 5,940 shares of the electric vehicle producer's stock, valued at approximately $2,671,000. Tesla comprises about 2.7% of Box Hill Private Wealth LLC's investment portfolio, making the stock its 7th largest position. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Cloud Capital Management LLC boosted its position in Tesla by 1.1% in the 3rd quarter. Cloud Capital Management LLC now owns 2,076 shares of the electric vehicle producer's stock valued at $923,000 after buying an additional 23 shares during the period. PFS Partners LLC boosted its position in Tesla by 4.2% in the 4th quarter. PFS Partners LLC now owns 590 shares of the electric vehicle producer's stock valued at $265,000 after buying an additional 24 shares during the period. Monte Financial Group LLC boosted its position in Tesla by 1.5% in the 3rd quarter. Monte Financial Group LLC now owns 1,644 shares of the electric vehicle producer's stock valued at $731,000 after buying an additional 25 shares during the period. Bank of Jackson Hole Trust boosted its position in Tesla by 1.0% in the 3rd quarter. Bank of Jackson Hole Trust now owns 2,497 shares of the electric vehicle producer's stock valued at $1,110,000 after buying an additional 25 shares during the period. Finally, Presidio Capital Management LLC boosted its position in Tesla by 0.6% in the 3rd quarter. Presidio Capital Management LLC now owns 3,996 shares of the electric vehicle producer's stock valued at $1,777,000 after buying an additional 25 shares during the period. Hedge funds and other institutional investors own 66.20% of the company's stock. Get Tesla alerts: Sign Up Insiders Place Their Bets In related news, CFO Vaibhav Taneja sold 3,000 share...